In mouse cancer cell lines and E-coli-related cancer models, it was found that after oxidative stress-related pathways were abnormally regulated, GPRC5A deletion would reduce cell proliferation, increase cell apoptosis, and inhibit the occurrence of tumors in vivo. Here, GPRC5A is linked to cancer.